NovoCure Ltd.

( )
NVCR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. 1.06%539.931.0%$848.78m
DHRDanaher Corp. 0.56%251.710.7%$688.29m
ABTAbbott Laboratories 1.50%114.890.8%$659.02m
ISRGIntuitive Surgical, Inc. 0.32%223.300.8%$512.02m
MDTMedtronic Plc -5.65%99.580.6%$496.77m
BSXBoston Scientific Corp. 0.18%40.161.0%$377.56m
ALGNAlign Technology, Inc. -0.63%274.836.4%$375.45m
IDXXIDEXX Laboratories, Inc. 4.64%384.923.8%$360.98m
SYKStryker Corp. -0.03%234.951.3%$344.49m
EWEdwards Lifesciences Corp. 1.77%98.560.4%$316.81m
BDXBecton, Dickinson & Co. -0.10%251.911.0%$311.50m
DXCMDexCom, Inc. -0.25%280.637.7%$311.47m
AAgilent Technologies, Inc. 2.81%123.761.6%$263.00m
BAXBaxter International, Inc. 0.69%75.711.8%$248.58m
MTDMettler-Toledo International, Inc. 2.35%1258.895.8%$196.60m

Company Profile

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.